Wednesday, 19 Feb 2020

You are here

MACE + VTE Across Upadacitinib Studies in RA Patients: Dr. Jonathan Kay

Dr. Kay discusses major adverse cardiovasular events in patients with RA at the 2019 ACR/ARP annual meeting in Atlanta.

Add new comment

Want to talk about this video? Comment here to lead the discussion.
MORE VIDEOS

Dr. Julio Gonzalez: Spondyloarthritis

23 Oct 2018

The RheumNow Week in Review – 12 May...

12 May 2017

Dr. Jack Cush at EULAR 2018: The Art of...

14 Jun 2018

QD Clinic - Change in DMARD or Not

21 Feb 2019

RheumNow Podcast – Upadacitinib FDA...

23 Aug 2019

RheumNow Week in Review – 11 November...

12 Nov 2016

Dr. Len Calabrese - Wine & the...

13 Nov 2016

Week in Review - 20 Feb 2016

24 Feb 2016

Dr. David Liew: Yellow Fever...

22 Oct 2018

Primer in Comorbidities in Lupus: Dr....

18 Nov 2019

Dr. Philip Mease: Risankizumab in...

18 Dec 2017

Scleroderma and the 15% Rule

17 Feb 2020